Amica Retiree Medical Trust Trims Position in Philip Morris International Inc. (NYSE:PM)

Amica Retiree Medical Trust trimmed its position in Philip Morris International Inc. (NYSE:PM) by 17.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 12,769 shares of the company’s stock after selling 2,672 shares during the period. Philip Morris International comprises 1.5% of Amica Retiree Medical Trust’s portfolio, making the stock its 12th biggest holding. Amica Retiree Medical Trust’s holdings in Philip Morris International were worth $1,537,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in PM. Meridian Wealth Partners LLC grew its position in Philip Morris International by 4.1% during the fourth quarter. Meridian Wealth Partners LLC now owns 1,781 shares of the company’s stock valued at $214,000 after buying an additional 70 shares during the period. NewSquare Capital LLC grew its position in shares of Philip Morris International by 53.7% during the 4th quarter. NewSquare Capital LLC now owns 206 shares of the company’s stock valued at $25,000 after acquiring an additional 72 shares during the period. Creative Financial Designs Inc. ADV increased its stake in shares of Philip Morris International by 2.1% in the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,628 shares of the company’s stock worth $437,000 after purchasing an additional 73 shares in the last quarter. Balboa Wealth Partners lifted its position in Philip Morris International by 2.0% during the fourth quarter. Balboa Wealth Partners now owns 3,712 shares of the company’s stock valued at $447,000 after purchasing an additional 74 shares in the last quarter. Finally, Centurion Wealth Management LLC grew its holdings in Philip Morris International by 3.5% during the fourth quarter. Centurion Wealth Management LLC now owns 2,229 shares of the company’s stock valued at $268,000 after purchasing an additional 75 shares during the period. 78.63% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, insider Werner Barth sold 10,000 shares of the firm’s stock in a transaction on Thursday, February 20th. The stock was sold at an average price of $148.67, for a total transaction of $1,486,700.00. Following the transaction, the insider now owns 106,244 shares in the company, valued at approximately $15,795,295.48. This trade represents a 8.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Lars Dahlgren sold 3,679 shares of the company’s stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $152.96, for a total transaction of $562,739.84. Following the completion of the sale, the insider now directly owns 26,828 shares of the company’s stock, valued at approximately $4,103,610.88. This trade represents a 12.06 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 131,822 shares of company stock valued at $19,655,585 in the last 90 days. Company insiders own 0.13% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on PM shares. JPMorgan Chase & Co. raised their price objective on Philip Morris International from $145.00 to $160.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 18th. Stifel Nicolaus upped their price target on shares of Philip Morris International from $145.00 to $160.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Argus upgraded shares of Philip Morris International from a “hold” rating to a “buy” rating in a research report on Friday, March 14th. StockNews.com downgraded shares of Philip Morris International from a “buy” rating to a “hold” rating in a report on Monday, February 10th. Finally, Morgan Stanley assumed coverage on Philip Morris International in a report on Thursday, January 16th. They set an “overweight” rating and a $140.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $144.56.

Philip Morris International Price Performance

Shares of NYSE PM opened at $154.27 on Thursday. The business’s 50 day moving average is $144.45 and its two-hundred day moving average is $131.75. The stock has a market capitalization of $239.87 billion, a P/E ratio of 34.21, a PEG ratio of 2.65 and a beta of 0.53. Philip Morris International Inc. has a 1-year low of $87.82 and a 1-year high of $159.51.

Philip Morris International (NYSE:PM) last announced its quarterly earnings data on Thursday, February 6th. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.06. Philip Morris International had a net margin of 7.89% and a negative return on equity of 120.08%. As a group, equities research analysts anticipate that Philip Morris International Inc. will post 7.14 earnings per share for the current fiscal year.

Philip Morris International Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 10th. Stockholders of record on Thursday, March 20th will be issued a $1.35 dividend. This represents a $5.40 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date is Thursday, March 20th. Philip Morris International’s payout ratio is presently 119.73%.

Philip Morris International Profile

Philip Morris International Inc operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches.